搜尋結果 Search results
品牌:「adi」約有 14855 項產品 / 頁數 496 - 18
品牌篩選:
名稱 | 規格 | 貨號 | 品牌 | 應用 |
---|---|---|---|---|
Terlipressin | 50 mg | RP-1508 | ADI | |
Teriparatide Acetate | 100 mg | PP-1730 | ADI | |
Tenascin-C (GBI-10) , DNA Aptamer, unlabeled | Custom | AD-147-U | ADI | |
Tenascin-C (GBI-10) , DNA Aptamer, FITC labeled | Custom | AD-147-F | ADI | |
Tenascin-C (GBI-10) , DNA Aptamer, Biotinylated | Custom | AD-147-B | ADI | |
TDB (Trehalose-6,6-dibehenate) Synthetic vaccine adjuvant | 2 mg | AV-9015-2 | ADI | |
Tax9, HTLV - 1 (11 - 19) (AA: Leu-Leu-Phe-Gly-Tyr-Pro-Val-Tyr-Val) (MW: 1070.31) | 5 mg | SP-64011-5 | ADI | |
Tax8, HTLV - 1 (12 - 19) (AA: Leu-Phe-Gly-Tyr-Pro-Val-Tyr-Val) (MW: 957.15) | 1 mg | SP-86611-1 | ADI | |
TAT peptide [H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2; MW: 1558.88] | 1 mg | SP-55380-1 | ADI | |
TAT 2-4 [H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-OH; MW: 3215.81] | 0.5 mg | SP-55225-1 | ADI | |
Taq DNA polymerase (TQ21) , DNA Aptamer, unlabeled | Custom | AD-146-U | ADI | |
Taq DNA polymerase (TQ21) , DNA Aptamer, FITC labeled | Custom | AD-146-F | ADI | |
Taq DNA polymerase (TQ21) , DNA Aptamer, Biotinylated | Custom | AD-146-B | ADI | |
Tak-285, dual Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%) | 5 mg | SM-101130-5 | ADI | |
Tak-285, dual Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%) | 25 mg | SM-101130-25 | ADI | |
Tachykinin (111-129) Beta-Prepro (Human) (AA: Ala-Leu-Asn-Ser-Val-Ala-Tyr-Glu-Arg-Ser-Ala-Met-Gln-Asn-Tyr-Glu-Arg-Arg-Arg) (MW: 2314.59) | 1 mg | SP-54736-1 | ADI | |
TACE (ADAM-17) (AA: Mca-Ser-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg-Lys(Dnp)-NH2) (MW: 1768.91) | 1 mg | SP-85225-1 | ADI | |
TA-0910, taltirelin (AA: 1-methyl-4,5-dihydroorotyl-His-Pro-NH2) (MW: 405.41) | 1 mg | SP-100286-1 | ADI | |
T7 tag (T7-tag, fusion tag) control/blocking peptide | 100 ug | T711-P | ADI | |
T4-BSA conjugate | 1 mg | T4BSA-1 | ADI | |
T3-BSA conjugate | 1 mg | T3BSA-1 | ADI | |
T22 (AA: Arg-Arg-Trp-Cys-Tyr-Arg-Lys-Cys-Tyr-Lys-Gly-Tyr-Cys-Tyr-Arg-Lys-Cys-Arg-NH2 (Disulfide bridge: Cys4- Cys17, Cys8-Cys13)) (MW: 2487.02) | 1 mg | SP-87447-1 | ADI | |
SYVPSAEQI, P-yoelii circumsporozoite protein (280–288), PyCSP (280–288) peptide | 1 mg | CSPY12-P | ADI | |
Systemin [H-Ala-Val-Gln-Ser-Lys-Pro-Pro-Ser-Lys-Arg-Asp-Pro-Pro-Lys-Met-Gln-Thr-Asp-OH; MW: 21.32] | 0.5 mg | SP-55162-1 | ADI | |
Syntide 2 [H-Pro-Leu-Ala-Arg-Thr-Leu-Ser-Val-Ala-Gly-Leu-Pro-Gly-Lys-Lys-OH; MW: 157.85] | 1 mg | SP-55141-1 | ADI | |
synthetic CD4 aptamer, RNA aptamer | Custom | AR-317-U | ADI | |
Synthetic Adjuvant Combo Pak-2 (contains 1 mg of Pam2csk4 (#AV-9020-1), 1 mg of Pam3csk4 (#AV-9025-1) and 1 mg of Poly(I:C) (#AV-9030) | 1 pk | AV-9000-PK-2 | ADI | |
Synthetic Adjuvant Combo Pak-1 (contains 1 mg of Gardiquimod (#AV-8010), Imiquimod (#AV-8015) and 1 mg R848 (#AV-8020-1) | 1 pk | AV-8000-PK-1 | ADI | |
Synaptobrevin-2 (75-78) (human, bovine, mouse, rat) (AA: Gln-Phe-Glu-Thr) (MW: 523.55) | 5 mg | SP-89799-5 | ADI | |
Synaptobrevin-2 (73-79) (human, bovine, mouse, rat) (AA: Ala-Ser-Gln-Phe-Glu-Thr-Ser) (MW: 768.78) | 5 mg | SP-89798-5 | ADI |